HomeInsightsStock Comparison

Acutaas Chemicals Ltd vs Amwill Health Care Ltd Stock Comparison

Acutaas Chemicals Ltd vs Amwill Health Care Ltd Stock Comparison

Last Updated on: Aug 08, 2025

Key Highlights

  • The Latest Trading Price of Acutaas Chemicals Ltd is ₹ 1292 as of 08 Aug 14:12.
  • The P/E Ratio of Acutaas Chemicals Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 yearsThe P/E Ratio of Amwill Health Care Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Acutaas Chemicals Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 yearsThe Market Cap of Amwill Health Care Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Acutaas Chemicals Ltd for the Jun '25 is ₹ 223.17 crore as compare to the Mar '25 revenue of ₹ 314.26 crore. This represent the decline of -28.99% The revenue of Amwill Health Care Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Acutaas Chemicals Ltd for the Jun '25 is ₹ 66.85 crore as compare to the Mar '25 ebitda of ₹ 90.74 crore. This represent the decline of -26.33% The ebitda of Amwill Health Care Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Acutaas Chemicals Ltd changed from ₹ 22.24 crore to ₹ 44.01 crore over 9 quarters. This represents a CAGR of 35.44% The net profit of Amwill Health Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Acutaas Chemicals Ltd changed from 15.19 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Amwill Health Care Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Acutaas Chemicals Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Amwill Health Care Ltd

  • Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name Amwill Health Care Private Limited', dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore.
  • Further, Company was converted into a Public Limited Company and a fresh Certificate of Incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore with the change in name to Amwill Health Care Limited'. Amwill Health Care Ltd is a derma-cosmetic development company, associated with contract manufacturers, distributor and third party product development agencies, which has enabled in developing capabilities, in manufacturing, packaging and distribution.
  • The core focus of Company is on development of problem solving dermatological, cosmeceutical and aesthetical products, and therefore to direct all efforts towards product formulation and development, the Company has outsourced key functions such as manufacturing, prototype development and distribution to third parties, for effective management and execution.

Acutaas Chemicals Ltd News Hub

News

Acutaas Chemicals spurts after Q1 PAT surges 199% YoY

In Q1 FY26, Acutaas Chemicals reported a 17.3% rise in consolidated revenue from operation...

Read more

31 Jul 2025 14:23

News

Acutaas Chemicals to discuss results

Acutaas Chemicals will hold a meeting of the Board of Directors of the Company on 30 July ...

Read more

25 Jul 2025 11:10

News

Baba Advance Materials enters in JV agreement with J & Materials Co.

Baba Advance Materials (BAML), a wholly owned subsidiary company of Acutaas Chemicals has ...

Read more

27 Jun 2025 19:30

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

Amwill Health Care Ltd News Hub

News

Amwill Health Care AGM scheduled

Amwill Health Care announced that the 8th Annual General Meeting(AGM) of the company will ...

Read more

09 Jul 2025 16:22

News

Amwill Health Care schedules board meeting

Amwill Health Care will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

28 May 2025 10:43

News

BSE SME Amwill Health Care drops on debut

The scrip was listed at 88.85, at a discount of 19.95% compared with the initial public of...

Read more

12 Feb 2025 10:50

SWOT Analysis Of Acutaas Chemicals Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Acutaas Chemicals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Acutaas Chemicals Ltd and Amwill Health Care Ltd

Which company has a larger market capitalization, Acutaas Chemicals Ltd or Amwill Health Care Ltd?

Market cap of Acutaas Chemicals Ltd is 10,599 Cr while Market cap of Amwill Health Care Ltd is 120 Cr

What are the key factors driving the stock performance of Acutaas Chemicals Ltd and Amwill Health Care Ltd?

The stock performance of Acutaas Chemicals Ltd and Amwill Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Acutaas Chemicals Ltd and Amwill Health Care Ltd?

As of August 8, 2025, the Acutaas Chemicals Ltd stock price is INR ₹1294.65. On the other hand, Amwill Health Care Ltd stock price is INR ₹60.38.

How do dividend payouts of Acutaas Chemicals Ltd and Amwill Health Care Ltd compare?

To compare the dividend payouts of Acutaas Chemicals Ltd and Amwill Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions